(Q73614293)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

title

Coenzyme Q10 in the central nervous system and its potential usefulness in the treatment of neurodegenerative diseases (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

0 references

1

M F Beal

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

author name string

R T Matthews

series ordinal

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

publication date

1 January 1997

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

Molecular Aspects of Medicine

5 November 2019

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

volume

18 Suppl

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

page(s)

S169-79

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

Marked reduction in CSF lactate and pyruvate levels after CoQ therapy in a patient with mitochondrial myopathy, encephalopathy, lactic acidosis and stroke-like episodes (MELAS)

5 November 2019

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Does impairment of energy metabolism result in excitotoxic neuronal death in neurodegenerative illnesses?

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Aging, energy, and oxidative stress in neurodegenerative diseases.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Coenzyme Q10 and nicotinamide block striatal lesions produced by the mitochondrial toxin malonate

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Clinical and biochemical correlations in mitochondrial myopathies treated with coenzyme Q10

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Aminooxyacetic acid striatal lesions attenuated by 1,3-butanediol and coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Elucidation of a tripartite mechanism underlying the improvement in cardiac tolerance to ischemia by coenzyme Q10 pretreatment

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Ubisemiquinones as obligatory intermediates in the electron transfer from NADH to ubiquinone

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Biochemical, physiological and medical aspects of ubiquinone function

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Ubiquinone protects cultured neurons against spontaneous and excitotoxin-induced degeneration

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Sensitive assay of hydroxyl free radical formation utilizing high pressure liquid chromatography with electrochemical detection of phenol and salicylate hydroxylation products.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Phosphorus magnetic resonance spectroscopy in the evaluation of mitochondrial myopathies: results of a 6-month therapy study with coenzyme Q.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Mitochondrial encephalomyopathy (MELAS): pathological study and successful therapy with coenzyme Q10 and idebenone

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Evidence for impairment of energy metabolism in vivo in Huntington's disease using localized 1H NMR spectroscopy

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Energy metabolism defects in Huntington's disease and effects of coenzyme Q10.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Long-term coenzyme Q10 therapy for a mitochondrial encephalomyopathy with cytochrome c oxidase deficiency: a 31P NMR study

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Relations between tocopherol depletion and coenzyme Q during lipid peroxidation in rat liver mitochondria

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

A protective effect of coenzyme Q10 on ischemia and reperfusion of the isolated perfused rat heart

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Coenzyme Q10 and nicotinamide and a free radical spin trap protect against MPTP neurotoxicity

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Involvement of free radicals in excitotoxicity in vivo.

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

Exogenous coenzyme Q (coq) fails to increase coq in skeletal muscle of two patients with mitochondrial myopathies

1 reference

https://api.crossref.org/works/10.1016%2FS0098-2997%2897%2900024-1

7 January 2021

10.1016/S0098-2997(97)00024-1

Identifiers

DOI

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:9266519%20AND%20SRC:MED&resulttype=core&format=json

5 November 2019

1 reference